Cephalon Slips in Late Trading
home > MSN news
... Sales of Provigil, for sleep disorders, rose 6% to $100.1 million; Actiq, a cancer pain treatment, gained 45% to $101.9 ...
- link to Cephalon Slips in Late Trading -
Last update: 05/26/2005
|
|
home > MSN news
... Sales of Provigil, for sleep disorders, rose 6% to $100.1 million; Actiq, a cancer pain treatment, gained 45% to $101.9 ...
- link to Cephalon Slips in Late Trading -
Last update: 05/26/2005